Home › Melanoma › Virginia › Arlington

Pag-aaral pangklinika para sa Melanoma sa Arlington, VA

Isang pag-aaral para sa Melanoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Arlington. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

Nagre-recruitPhase 1

Inova Schar Cancer Institute, Fairfax · 11 mi ang layo
NEXT Virginia, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06270706

Phase 1 Study of PF-08046033 in Advanced Solid Tumors

Nagre-recruitPhase 1

Inova Schar Cancer Infusion Pharmacy, Fairfax · 11 mi ang layo
Inova Schar Cancer, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07519655

A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)

Nagre-recruitPhase 2

Inova Schar Cancer Institute ( Site 4046), Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT06961006

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

Nagre-recruitPhase 2

Inova Fairfax Hospital, Falls Church · 4 mi ang layo
Inova Schar Cancer Institute, Fairfax · 11 mi ang layo
Inova Fair Oaks Hospital, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT05136196

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

Nagre-recruitPhase 3

Inova Schar Cancer Institute, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06246916

Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

Nagre-recruitPhase 1/2

Virginia Cancer Specialists-Fairfax, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 4, 2026 · NCT07287917

A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors

Nagre-recruitPhase 1

Virginia Cancer Specialists, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT04913285

Project: Every Child for Younger Patients With Cancer

Nagre-recruitObservasyonal na pag-aaral

Inova Fairfax Hospital, Falls Church · 4 mi ang layo

Hanggang edad 25 · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT02402244

A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

Nagre-recruitPhase 1/2

Research Site, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 19, 2026 · NCT07115043

A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors

Nagre-recruitPhase 1/2

Clinical Trial Site, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT07749586

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

Nagre-recruitPhase 1/2

Virginia Cancer Specialists, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 5, 2026 · NCT06330064

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Nagre-recruitPhase 1/2

Next Oncology Virginia, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update May 15, 2026 · NCT05379985

A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors

Nagre-recruitPhase 1

NEXT Oncology - Virginia, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 20, 2026 · NCT06326411

A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors

Nagre-recruitPhase 1

NEXT Virginia, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Ene 21, 2026 · NCT07317505

Study to Evaluate LB-LR1109, Administered Alone for the Treatment of Solid Tumor and in Combination With Atezolizumab for the Treatment of NSCLC

Nagre-recruitPhase 1

NEXT Oncology, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 24, 2025 · NCT06332755

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

Nagre-recruitPhase 1/2

Research Site 102, Fairfax · 11 mi ang layo
Research Site 112, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 21, 2025 · NCT05914116

A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors

Nagre-recruitPhase 1/2

Virginia Cancer Specialists, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 8, 2025 · NCT04370587

A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies

Nagre-recruitPhase 1/2

Virginia Cancer Specialists, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Peb 13, 2025 · NCT05669430

A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents

Nagre-recruitPhase 1/2

NEXT Virginia, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Ene 7, 2025 · NCT06090266

A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors

Nagre-recruitPhase 1

Next Oncology, Virginia Cancer Specialists, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Ene 26, 2024 · NCT05746897

Pag-aaral para sa Melanoma sa ibang lungsod

Iba pang pag-aaral sa Arlington

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.